VAERS Explorer
Back to explore

Report #2896234

Received May 12, 2026

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Male
Age
67 yrs
State
NJ
Recovered
Not recovered
Vaccinated
Jan 1, 2026
Onset
Feb 28, 2026
Days to onset
58
Hospital days

Vaccines (2)

TypeNameManufacturerDoseLotRoute / Site
VARZOSZOSTER (SHINGRIX)GLAXOSMITHKLINE BIOLOGICALS2
VARZOSZOSTER (SHINGRIX)GLAXOSMITHKLINE BIOLOGICALS1

Symptoms (2)

ArthralgiaGout

Symptom narrative

Gout; deep join pain in his right foot; f SHINGRIX early January 2026 and his second dose on the last day of February; This non-serious case was reported by a consumer via call center representative and described the occurrence of gout in a 67-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis. Co-suspect products included Herpes zoster (Shingrix) for prophylaxis. Concurrent medical conditions included blood cholesterol increased (High cholesterol). On 28-FEB-2026, the patient received the 2nd dose of Shingrix. In JAN-2026, the patient received the 1st dose of Shingrix. On 28-FEB-2026, an unknown time after receiving Shingrix and not applicable after receiving Shingrix, the patient experienced drug dose administration interval too short (Verbatim: f SHINGRIX early January 2026 and his second dose on the last day of February). On 08-APR-2026, the patient experienced gout (Verbatim: Gout) and foot joint pain (Verbatim: deep join pain in his right foot). The patient was treated with simvastatin and meloxicam. The outcome of the gout and foot joint pain were resolving and the outcome of the drug dose administration interval too short was not applicable. It was unknown if the reporter considered the gout and foot joint pain to be related to Shingrix and Shingrix. It was unknown if the company considered the gout and foot joint pain to be related to Shingrix and Shingrix. Additional Information: GSK Receipt Date: 04-MAY-2026 The reporter was the patient who received his first dose of Shingrix early January 2026 and his second dose on the last day of February. He stated that he had developed deep joint pain in his right foot which his doctor thought was gout. He had been taking meloxicam 15 mg daily for the past 4 days and the pain had gotten slightly better. The batch number was not provided upon follow up with the reporter.

Current illness

Blood cholesterol increased (High cholesterol)